Henry Nnaemeka Ogbonna

Mr. Henry Nnaemeka Ogbonna

University of Alabama at Birmingham, Birmingham, Alabama, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2020 in Journal of Complementary and Alternative Medical Research
Verified
Journal Article
Open access
PDF file
UNUgonna D. Nwankpa
Ugonna D. Nwankpa
HOHenry Nnaemeka Ogbonna
Henry Nnaemeka Ogbonna
CUChinedu E. Udekwu
Chinedu E. Udekwu
CNChibuzo Valentine Nwokafor
Chibuzo Valentine Nwokafor
Aim: To evaluate the nephrotoxic and hepatotoxic potentials of artesunate in humans. Place and Duration of Study: Department of Biochemistry, Michael Okpara University of Agriculture, Umudike, Abia State, Nigeria, between November and December 2019. Methodology: 70 blood samples were collected from 35 normal individuals (control group), and 35 malaria patients treated with parenteral artesunate (treatment group). These were analyzed for biochemical parameters, including blood urea nitrogen (BUN), creatinine, total bilirubin, aspartate transaminase (AST), alanine transaminase (ALT), and alkaline phosphatase (ALP). The treatment group was further regrouped according to gender (19 males and 16 females), age (20 patients aged 20-29 and 15 patients aged 30-40 years) and duration of treatment (29 patients on 3rd or 4th day and 6 patients on 5th or 6th day of treatment). Biochemical tests were carried out using standard Randox test kits. One-way ANOVA was done on the parameters using statistical package for social sciences (SPSS), and comparisons were made. Results: Compared to control group, the treatment group showed significant increases (p<0.05) in BUN (15.89+1.30 against 11.69+0.62), Creatinine (0.96+0.62 against 0.82+0.03) and AST (22.14+2.45 against 16.66+0.85), a non-significant increase (p 0.05) in ALT (26.57+3.18 against 21.66+2.56) and ALP (85.31+4.06 against 77.54+3.09) and a non-significant decrease (p 0.05) in total bilirubin (0.59+0.06 against 0.65+0.06). However, all parameters examined were within the normal ranges. There was no significant relationship found in any parameter in a comparison of gender, age and duration of treatment. Conclusion: Since all parameters examined were in the normal ranges, administration of artesunate in the recommended dosage and the right duration may not have any significant toxic effect on the kidney and liver. However, further studies may be necessary to ascertain if the observed elevations could be attributed wholly to artesunate or other medications taken by the malaria patients.

7 May 2020 in International Journal of Biochemistry Research & Review
Verified
Journal Article
Open access
PDF file
HOHenry Nnaemeka Ogbonna
Henry Nnaemeka Ogbonna
UNUgonna D. Nwankpa
Ugonna D. Nwankpa
GAGodwin S. Aloh
Godwin S. Aloh
RIRaymond C. Ibeh
Raymond C. Ibeh
Background: Carica papaya is commonly used in the treatment of various diseases like constipation, piles, hypertension and malaria. The ameliorative effect of Carica papaya on alloxan-induced diabetic rats has been suggested by several studies. Aim: The present study aims to investigate the effect of methanolic extract of unripe Carica papaya pulp on the lipid profile and liver biomarkers of a diabetic rat. Materials and Methods: After acclimatization, thirty-two (32) animals were randomly classified into 8 groups (4 rats per group). The different test (extract) groups received in addition to normal diet ad libitum, dosages of 200, 400, 600 and 1000 mg/kg/day of the Carica papaya extract. The normal and negative control groups received a normal diet, while the positive control was given oral treatment with 6 mg/65 kg/day of glibenclamide as well as the normal diet. After 28 successive days of treatment, all the experimental rats were sacrificed by ocular puncture and the serum used in the evaluation of body lipids, liver function parameters and biochemical indexes. Results: The administration of the unripe Carica papaya extract resulted in a dose-dependent and significant decrease (p<0.05) in serum albumin, aspartate aminotransferase (AST), total protein, and in alanine aminotransferase (ALT) level. There was, however, a significant increase in High-density lipoprotein (HDL) level for 400-1000 mg/kg extract groups. The result also showed a reduced cholesterol level at an extract dose of 1000 mg/kg/day. Conclusion: The ameliorative properties of the unripe pulp of Carica Papayaon biochemical parameters of a diabetic rat, as shown from the result could be indicative that unripe Carica papaya can be valuable in the management of diabetes mellitus and other complications that may arise.

4 October 2024 in Cancers
Verified
Journal Article
Open access
PDF file
HOHenry Nnaemeka Ogbonna
Henry Nnaemeka Ogbonna
ZRZachary William Garrett Roberts
Zachary William Garrett Roberts
NGNicholas Godwin
Nicholas Godwin
PMPia Muri
Pia Muri
WTWilliam James Turbitt
William James Turbitt
Lyse A. NorianLyse A. Norian
Lyse A. Norian
Background/Objectives: Ketone esters (KEs) exhibit promise as anti-cancer agents but their impact on spontaneous metastases remains poorly understood. Although consumption of a ketogenic diet (KD) that is low in carbohydrates and high in fats can lead to KE production in vivo, the restrictive composition of KDs may diminish adherence in cancer patients. Methods: We investigated the effects of an exogenous ketone ester-supplemented (eKET), carbohydrate-replete diet on tumor growth, metastasis, and underlying mechanisms in orthotopic models of metastatic breast (4T1-Luc) and renal (Renca-Luc) carcinomas. Mice were randomized to diet after tumor challenge. Results: Administration of KEs did not alter tumor cell growth in vitro. However, in mice, our eKET diet increased circulating β-hydroxybutyrate and inhibited primary tumor growth and lung metastasis in both models. Body composition analysis illustrated the overall safety of eKET diet use, although it was associated with a loss of fat mass in mice with renal tumors. Immunogenetic profiling revealed divergent intratumoral eKET-related changes by tumor type. In mammary tumors, Wnt and TGFβ pathways were downregulated, whereas in renal tumors, genes related to hypoxia and DNA damage repair were downregulated. Conclusions: Thus, our eKET diet exerts potent antitumor and antimetastatic effects in both breast and renal cancer models, albeit with different modes of action and physiologic effects. Its potential as an adjuvant dietary approach for patients with diverse cancer types should be explored further.

22 March 2024 in Cancer Research
Verified
Journal Article
Closed access
HOHenry Nnaemeka Ogbonna
Henry Nnaemeka Ogbonna
ZRZachary Roberts
Zachary Roberts
HKHaley Kvarnberg
Haley Kvarnberg
FDFrancesca Dempsey
Francesca Dempsey
PSPatrick N. Song
Patrick N. Song
LNLyse Norian
Lyse Norian
Obesity is linked to an increased risk of various cancers, including renal cell carcinoma (RCC). Many RCC patients have obesity at diagnosis and treatment initiation, and our lab has found that this significantly impairs immunotherapy outcomes. Both preclinical and clinical reports, from our lab and others, have demonstrated that obesity reduces the efficacy of CD8+ T cell-dependent immunotherapy by increasing pro-tumorigenic IL-1β. Combining anti-PD-1 based therapy with anti-IL-1β triggers the recruitment of CD8+ T cells and improves the efficacy of anti-PD-1 based immunotherapy. However, the mechanistic links between obesity and increased IL-1β production remains unknown. Our objective is to identify mechanisms promoting IL-1 β-driven immunosuppression within renal tumors of obese mice. In our in vivo studies, we utilized a BALB/c mouse model of diet-induced obesity (DIO) and lean controls in combination with the Renca-Luc RCC cell line. Using flow cytometry and western blot, we respectively assessed leukocyte populations producing IL-1β and tumor energetics. Flow cytometry revealed that intra-tumoral IL-1β is produced primarily by tumor associated macrophages (TAMS). Immunoblotting demonstrated that increased IL-1β production is linked to altered mitochondrial function and ATP production. These early findings support the hypothesis that obesity driven IL-1β expression is mediated by tumor-associated macrophages and that mitochondrial dysfunction drives immune suppression. Understanding these molecular and immune-related mechanisms may pave the way for novel strategies to reduce immunosuppression in obese RCC patients, thus improving immunotherapeutic efficacy and overall clinical outcomes.Citation Format: Henry Nnaemeka Ogbonna, Zachary Roberts, Haley Kvarnberg, Francesca Dempsey, Patrick N. Song, Anna G. Sorace, Lyse Norian. Investigating the role of host obesity in promoting immunotherapy resistance [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3980. Obesity is linked to an increased risk of various cancers, including renal cell carcinoma (RCC). Many RCC patients have obesity at diagnosis and treatment initiation, and our lab has found that this significantly impairs immunotherapy outcomes. Both preclinical and clinical reports, from our lab and others, have demonstrated that obesity reduces the efficacy of CD8+ T cell-dependent immunotherapy by increasing pro-tumorigenic IL-1β. Combining anti-PD-1 based therapy with anti-IL-1β triggers the recruitment of CD8+ T cells and improves the efficacy of anti-PD-1 based immunotherapy. However, the mechanistic links between obesity and increased IL-1β production remains unknown. Our objective is to identify mechanisms promoting IL-1 β-driven immunosuppression within renal tumors of obese mice. In our in vivo studies, we utilized a BALB/c mouse model of diet-induced obesity (DIO) and lean controls in combination with the Renca-Luc RCC cell line. Using flow cytometry and western blot, we respectively assessed leukocyte populations producing IL-1β and tumor energetics. Flow cytometry revealed that intra-tumoral IL-1β is produced primarily by tumor associated macrophages (TAMS). Immunoblotting demonstrated that increased IL-1β production is linked to altered mitochondrial function and ATP production. These early findings support the hypothesis that obesity driven IL-1β expression is mediated by tumor-associated macrophages and that mitochondrial dysfunction drives immune suppression. Understanding these molecular and immune-related mechanisms may pave the way for novel strategies to reduce immunosuppression in obese RCC patients, thus improving immunotherapeutic efficacy and overall clinical outcomes.Citation Format: Henry Nnaemeka Ogbonna, Zachary Roberts, Haley Kvarnberg, Francesca Dempsey, Patrick N. Song, Anna G. Sorace, Lyse Norian. Investigating the role of host obesity in promoting immunotherapy resistance [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3980.

10 July 2023 in Research Square
Verified
Preprint
Open access
PDF file
RURobert Ikechukwu Uroko
Robert Ikechukwu Uroko
SISolomon Nnah Ijioma
Solomon Nnah Ijioma
HOHenry Nnaemeka Ogbonna
Henry Nnaemeka Ogbonna
CAChinedu Aguwamba
Chinedu Aguwamba
KUKingsley Chijioke Ugwuanyi
Kingsley Chijioke Ugwuanyi
Background:Aju Mbaiseis a combination of herbs that is widely used in the southeast part of Nigeria for the purpose of managing postpartum complications and alleviating menstrual pain. The study aimed at assessing the analgesic, anti-inflammatory, and anti-diarrheal properties ofAju mbaiseextract in rats. Methods: The extract was subjected to phytochemical analysis and acute toxicity testing. Subsequently, the anti-diarrheal effects of the extract were evaluated by administering charcoal as a meal and then using the castor oil-induced models. The evaluation of its anti-inflammatory effects was conducted through the carrageenan-induced paw oedema model, while its analgesic properties were assessed using the acetic acid-induced pain model. Results: Alkaloids, tannins, phenols, steroids, cardiac glycosides, terpenoids, flavonoids, and saponins were among the components that the phytochemical study revealed to be present. The acute toxicity value was also greater than 5000 mg/kg body weight. In animal studies, the extract displayed significant inhibitory effects on intestinal motility, while also reducing the wet stool frequency. The castor oil-induced model exhibited a decrease in the weight of intestinal contents and an elevation in serum electrolyte levels. Additionally, in the anti-inflammatory study, the extract was observed to suppress paw oedema, and in the analgesic study, it demonstrated a reduction in acetic acid-induced pain in rats. Conclusions: TheAju mbaisepolyherbal extract possesses anti-diarrhoeal, anti-inflammatory, and analgesic properties, making it a potentially safe option for managing diarrhoea, inflammation, and pain. These therapeutic effects may be attributed to the extract's composition of alkaloids, tannins, phenols, steroids, cardiac glycosides, terpenoids, flavonoids, and saponins. Nonetheless, additional research is necessary to establish the extract's ideal dosages and potential adverse effects.